/Investor DB

Levensohn Venture Partners

Venture capital

Geneva · Seed–Series A · 1 people tracked

Find your way into Levensohn Venture Partners

Sign up to see every warm intro you have to Levensohn Venture Partners

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Levensohn Venture Partners team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Founded by Pascal Levensohn, the firm invests in seed and early-stage technology startups through affiliated investment partnerships, having deployed over $600 million since 1996. Since 2014 it has pursued a diversified global investing strategy spanning aerospace, augmented reality, advanced digital signal processing, artificial intelligence, robotics, bioinformatics, and neurodegeneration. The practice emphasizes long-term active investing, corporate governance, and stewardship, with the founder serving as fiduciary director or board observer on multiple US- and Europe-based venture-backed companies. Levensohn Swiss operates from Geneva, Switzerland, reflecting a transatlantic focus across the United States and Europe.

Source: firm website, verified Sep 20, 2026.

Stage
Seed–Series A
HQ
Geneva, CH
Instruments
Equity
Founded
1996
Last 12 months
1 investment
Tracked investments
18

Team · 1 people

from the firm's website

What they invest in

from 8 of 18 portfolio companies

AI & Machine Learning ×4Biotech ×4Enterprise Software ×3Healthtech ×3Cybersecurity ×2Deep Tech ×2Digital Health ×2Medical Devices ×2

HQs:United States×4Switzerland×2Hong Kong×1Netherlands×1

Investments · 18 tracked

founders shown can be your intro path

By year:2026 · 12019 · 22018 · 12017 · 12016 · 12015 · 12014 · 12012 · 12011 · 12007 · 313 dated

Airspaceairspace.coinSeries A · Mar 2018 · $20M

Airspace provides end-to-end airspace protection solutions for urban environments, critical infrastructure, large-scale events, and high-security zones.

AI & Machine LearningCybersecurityDeep TechDefense TechEnterprise SoftwareGovTech

Jaz Banga(Founder)in

Co-investorsDBL PartnersGranite HillDefy PartnersHarbourVest Partners (Canada)Scale Venture PartnersScale Ventures+2 more

Bitglassforcepoint.comin𝕏Series B · Aug 2014 · $25M

Forcepoint provides a data security platform that discovers, classifies, and protects sensitive data across cloud, web, endpoint, email, and network environments.

AI & Machine LearningCybersecurityEnterprise SoftwareCampbell, US

BALAS NATARAJAN KAUSIK(Co-Founder & Chief Executive Officer)ANURAG KAHOL(Co-Founder & Chief Technology Officer)inANOOP BHATTACHARJYA(Executive Officer)CHRISTOPHER CHAN(Executive Officer)inANDREW URUSHIMA(Executive Officer)RICH CAMPAGNA(Chief Marketing Officer)

Co-investorsAllegisCyber CapitalFrancisco PartnersIn-Q-TelJavelin Venture PartnersNew Enterprise Associates (NEA)Norwest Venture Partners+5 more

Dolby Family Venturesdolbyventures.com

Dolby Ventures is an investment firm focused on life sciences, investing across precision neuroscience (neurodegeneration, psychiatry, and neurotech via therapeutics, devices, and diagnostics) and life sciences platforms such as de novo platforms, regenerative medicine, and computational biology.

AI & Machine LearningBiotech

Co-investorsAlumni VenturesFuture VenturesGaingelsTrue Ventures

Genomsysgenomsys.cominSeries A · Sep 2019 · $9M

GenomSys develops modular software for storing, processing and sharing genomic data based on the ISO/IEC 23092 MPEG-G standard, serving diagnostic laboratories, hospitals, research centers and biotech companies.

BiotechData & InfrastructureDigital HealthHealthtechSaaSLugano, CH

Antonio Aitoro(Chief Executive Officer)in

Co-investorsElysia Capital

Lightformlightform.comin𝕏Seed · Nov 2017 · $5M

Lightform develops design tools for projected augmented reality, combining computer vision and hardware to enable interactive visual experiences.

AI & Machine LearningDeep TechDeveloper ToolsHardware

Co-investorsComet LabsDolby Family VenturesGen CapitalPresence CapitalTuesday CapitalAnorak Ventures+2 more

Modsy_modsy.comSeries A · Feb 2016 · $8M

Shanna Tellerman(Founder)in

Co-investorsAdvance Venture PartnersComcast VenturesGotham Gal VenturesGV (Google Ventures)

Salvia Bioelectronicssalviabioelectronics.com

Neuromodulation therapy for migraine relief.

Eindhoven, NL

Hubert Martens(Co-founder; Chief Executive Officer)Daniel Schobben(Co-founder; Chief Innovation Officer)Dr. Wim Pollet(Co-founder; Chief Medical Officer)

Co-investorsDolby Family VenturesInkefInnovation IndustriesPanakes PartnersSHS CapitalThuja Capital

Therini Biotherinibio.cominSeed · Jul 2019 · $9M

Therini Bio is a biotechnology company developing fibrin-targeting therapeutics to treat neurological and ophthalmological diseases, leveraging scientific discoveries in neurovascular and neuroimmune mechanisms of disease.

BiotechDigital HealthHealthtechMedical DevicesSacramento, US

Katerina Akassoglou(Scientific Founder, Director of the Center for Neurovascular Brain Immunology and Professor of Neurology at UCSF and Gladstone Institutes)inKaterina Akassoglou, PhD(Scientific Founder)Leslie Schulze(Executive Officer)Tara Nickerson(Executive Officer, Director)in

BoardOlga Danilchanka(Director)inLaia Crespo-Martin(Director)

Co-investorsMRL Ventures FundSanofi VenturesSV Health InvestorsAngelini VenturesDementia Discovery FundDolby Family Ventures+2 more

Vandriavandria.comin

Vandria is a pharmaceutical development company focused on translating scientific innovation into first-in-class therapeutics.

BiotechHealthtechLongevityMedical DevicesLausanne, CH

Patrick Aebischer(Co-founder)Pénélope Andreux(Head of Research (mitochondrial research and development))inKlaus Dugi(Chief Medical Officer / Medical Leadership)inPeter(Business Development & Entrepreneurship Leadership)Leila(Operations Leadership)Anke Post(Chief Medical Officer / Neuroscience Leadership)

Co-investors+ND CapitalDolby Family VenturesApollo Health Ventures

Vuclipvuclip.comNov 2012 · $13M

The page presents PCCW Group, a Hong Kong-based company offering products and services for both consumer and business customers, with sections covering investor relations, sustainability, and media.

Enterprise SoftwareMedia & EntertainmentHong Kong, HK

Co-investorsIcon VenturesNew Enterprise Associates (NEA)SingTel Innov8 Pte Ltd.

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Akros SiliconAntheiaCure Network Dolby Acceleration PartnersDigiLens, Inc.HoojaMixed DimensionsSentillaSoundThinking

Portfolio news

latest coverage across their companies
Forcepoint Raises $18.0M Funding | Signalbase

Bitglass · trysignalbase.com · May 12, 2026

Frequently asked questions

How many investments has Levensohn Venture Partners made?
Levensohn Venture Partners has 18 tracked investments, including 1 dated in the last 24 months.
What stage does Levensohn Venture Partners invest at?
Levensohn Venture Partners invests at the Seed, Series A stages.
What sectors does Levensohn Venture Partners focus on?
Levensohn Venture Partners focuses on AI & Machine Learning, Biotech, Deep Tech, Robotics, Space Tech.
Where is Levensohn Venture Partners located?
Levensohn Venture Partners is headquartered in Geneva, CH.
Who does Levensohn Venture Partners co-invest with?
Levensohn Venture Partners most often shares deals with Dolby Family Ventures, Inkef, Innovation Industries, among 4 tracked co-investors.

Similar investors

Featured in lists